These Healthcare stocks are trading higher:
-Longeveron Inc (LGVN) stock is trading at $28.52, a gain of $11.3, or 65.62%, on high volume. Longeveron Inc gets a Sentiment Score of Neutral from InvestorsObserver.
-Ocuphire Pharma Inc (OCUP) stock is trading at $4.30, a gain of $0.82, or 23.28%, on high volume. Ocuphire Pharma Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.75.
-Augmedix Inc (AUGX) stock is trading at $3.42, a rise of $0.52, or 17.93%, on low volume. Augmedix Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.25.
-Finch Therapeutics Group Inc (FNCH) stock is trading at $15.89, a gain of $2.35, or 17.32%, on average volume. Finch Therapeutics Group Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.00.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Qualigen Therapeutics Inc (QLGN) stock is trading at $1.55, a decline of $1.01, or 39.84%, on high volume. Qualigen Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver with a price target of $9.00.-Vallon Pharmaceuticals Inc (VLON) stock is trading at $4.81, a drop of $2.49, or 34.25%, on high volume. Vallon Pharmaceuticals Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy.
-Aptevo Therapeutics Inc (APVO) stock is trading at $11.48, a decline of $5.55, or 32.59%, on high volume. Aptevo Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $52.50.
-Pasithea Therapeutics Corp (KTTA) stock is trading at $3.88, a loss of $1.71, or 29.73%, on high volume. Pasithea Therapeutics Corp gets a Sentiment Score of Bullish from InvestorsObserver.